ID   NCC-MRT1-C1
AC   CVCL_C4MW
DR   Wikidata; Q116049880
RX   PubMed=35927606;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 30 hours (PubMed=35927606).
CC   Sequence variation: Gene deletion; HGNC; 11103; SMARCB1; Zygosity=Homozygous (PubMed=35927606).
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=35927606
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D21S11: 31.2,33.2
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 30-01-24; Version: 4
//
RX   PubMed=35927606; DOI=10.1007/s13577-022-00751-z;
RA   Akiyama T., Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T.,
RA   Sato C., Kojima N., Yoshida A., Kawai A., Ohtori S., Kondo T.;
RT   "Establishment and characterization of NCC-MRT1-C1: a novel cell line
RT   of malignant rhabdoid tumor.";
RL   Hum. Cell 35:2002-2010(2022).
//